{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:08:55Z","timestamp":1791104935679,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6738,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1111\/j.1538-7836.2004.00767.x","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T12:07:50Z","timestamp":1100520470000},"page":"1096-1103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey"],"prefix":"10.1016","volume":"2","author":[{"given":"M\u2010C.","family":"Poon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"D'Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Von Depka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Khair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"N\u00e9grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Karafoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Huth\u2010Kuehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Morfini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0010","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann's thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0015","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-0037-1615867","article-title":"Inherited abnormalities of platelets","volume":"82","author":"Nurden","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood.V51.6.1065.1065","article-title":"Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function","volume":"51","author":"Levy\u2010Toledano","year":"1978","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00062752-199811000-00008","article-title":"Transfusion\u2010transmissible infections","volume":"5","author":"Vrielink","year":"1998","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1055\/s-0037-1615388","article-title":"Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors","volume":"80","author":"Key","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0035","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1365-2516.1998.00209.x","article-title":"A randomized, double\u2010blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group","volume":"4","author":"Lusher","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0045","first-page":"981","article-title":"A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa","volume":"75","author":"Tengborn","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0050","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V94.11.3951","article-title":"Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia","volume":"94","author":"Poon","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.2003.04286.x","article-title":"The use of recombinant factor VIIa in children with inherited platelet function disorders","volume":"121","author":"Almeida","year":"2003","journal-title":"Br J Haematol"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2004.00767.x_bb0060","first-page":"621","article-title":"Recombinant activated factor VII as haemostatic agent in Glanzmann's thrombasthenia","volume":"82","author":"Musso","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0065","first-page":"349","article-title":"Thrombotic complications in two patients receiving NovoSeven\u00ae","volume":"6","author":"Robinson","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0037-1613884","article-title":"Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures","volume":"83","author":"D'Oiron","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2141.2001.02873-6.x","article-title":"Use of recombinant factor VIIa for post\u2010operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies","volume":"114","author":"Patel","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0080","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1023\/A:1019605803467","article-title":"Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia","volume":"47","author":"Van Buuren","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0085","first-page":"64","article-title":"Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb\/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions","volume":"45","author":"Devecioglu","year":"2003","journal-title":"Turk J Pediatr"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00001721-200302000-00011","article-title":"Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia","volume":"14","author":"Chuansumrit","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/08880010390220135","article-title":"Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia","volume":"20","author":"Caglar","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2004.00767.x_bb0100","first-page":"256","article-title":"Recombinant factor VIIa in congenital platelet bleeding disorders","volume":"96","author":"Poon","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-16890","article-title":"Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development","volume":"27","author":"Jurlander","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI118859","article-title":"Inhibition of platelet\u2010mediated, tissue factor\u2010induced thrombin generation by the mouse\/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and \u2018clinical restenosis\u2019","volume":"98","author":"Reverter","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high\u2010dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0120","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell\u2010based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2000-8454","article-title":"The regulation of the factor VII\u2010dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders","volume":"26","author":"Van't Veer","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1537-2995.2003.00427.x","article-title":"Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders","volume":"43","author":"Galan","year":"2003","journal-title":"Transfusion"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2004.00767.x_bb0135","first-page":"518a","article-title":"Polymeric fibrin interacts with platelets independently from integrin \u03b1IIb\u03b23","volume":"98","author":"Osdoit","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0140","doi-asserted-by":"crossref","first-page":"21173","DOI":"10.1074\/jbc.M008249200","article-title":"Unique pathway of thrombin\u2010induced platelet aggregation mediated by glycoprotein Ib","volume":"276","author":"Soslau","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0145","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor\u2010independent thrombin generation","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0609.1981.tb00467.x","article-title":"Pregnancy and parturition in a patient with severe Glanzmann's thrombasthenia","volume":"27","author":"Sundqvist","year":"1981","journal-title":"Scand J Haematol"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2004.00767.x_bb0155","first-page":"P1154","article-title":"Glanzmann thrombasthenia and pregnancy: clinical observations and management of four affected women","author":"Boval","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0160","first-page":"40","article-title":"Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann's thrombasthenia and multiple anti\u2010platelet antibodies","volume":"61","author":"Ito","year":"1991","journal-title":"Vox Sang"},{"key":"10.1111\/j.1538-7836.2004.00767.x_bb0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2141.2002.03936.x","article-title":"Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti\u2010glycoprotein IIb\u2010IIIa antibodies","volume":"119","author":"Martin","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2004.00767.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622180086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622180086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2004.00767.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:30:28Z","timestamp":1761532228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622180086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1538783622180086"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00767.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00767.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}